
Dan Simenc
FSA, MAAA
Principal and Consulting Actuary
Tampa, FL, US
Dan Simenc is a principal and consulting actuary with the Milliman Tampa office. He joined the firm in February 2012.
Experience
Dan has extensive experience helping payers, manufacturers, providers, and employers navigate the U.S. health insurance landscape with an emphasis on Medicare Advantage and Part D. His work includes pricing, rate filings, financial reporting, market access strategy, and real-world evidence research.
Professional Designations
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
Education
- BA, Mathematics, Boise State University
- BS, Economics, Boise State University
Affiliations
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
Publications
Read their latest work
Article
Medicare drug price negotiation: New dynamics as the tide turns to Medicare Part B
18 February 2026 - by Katherine M. Holcomb, Jake K. Klaisner, Dan Simenc
Medicare drug price negotiation: With the first cycle where Part B drugs are eligible to be selected, the implications extend far beyond simple price reductions.
Article
Medicare drug price negotiation: Navigating the next wave of maximum fair prices
12 January 2026 - by Jake K. Klaisner, Katherine M. Holcomb, Dan Simenc
Deeper discounts in the latest round of negotiated prices for Medicare Part D drugs may indicate how future negotiations will play out.
Article
Adapting to the IRA: 5 manufacturer considerations for Part D formulary access negotiations
08 December 2025 - by Dan Simenc, Pepper Huang
We discuss five key considerations for manufacturers negotiating Medicare Part D formulary access in the wake of the Inflation Reduction Act.
Article
Medicare price negotiation: Year 2 selection expands to new therapeutic areas
07 February 2025 - by Dan Simenc, Jake K. Klaisner, Katherine M. Holcomb
We provide some insights on Medicare price negotiation's year-two selection, which expands to new therapeutic areas.